Antiviral Drug Discovery and Development for Mayaro Fever - What do we have so far?

Marcos V P Mello1,2, Thaisa F S Domingos1, Davis F Ferreira3,4

  • 1Laboratory of Molecular Modeling & QSAR (ModMolQSAR), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Insights

Mayaro virus (MAYV) causes Mayaro fever, a disease with symptoms similar to Dengue and Zika. New antiviral drugs are urgently needed as no vaccine or treatment currently exists for MAYV.

Area of Science:

  • * Tropical infectious diseases and emerging viral threats.
  • * Virology and arbovirus research.
  • * Drug discovery and development for infectious diseases.

Background:

  • * Mayaro virus (MAYV) is an emerging arbovirus responsible for Mayaro fever, prevalent in tropical regions.
  • * Mayaro fever symptoms (fever, headache, arthralgia, rash) overlap with other arboviruses like Dengue, Zika, and Chikungunya, complicating diagnosis.
  • * MAYV poses a significant threat for large-scale epidemics, similar to Zika virus (ZIKV) and Chikungunya virus (CHIKV).

Purpose of the Study:

  • * To review existing studies on anti-MAYV derivatives.
  • * To emphasize the critical need for novel antiviral drug candidates against Mayaro fever.
  • * To highlight the potential of MAYV as a significant public health concern.

Main Methods:

  • * Mini-review of published literature on anti-MAYV research.
  • * Analysis of studies focusing on potential antiviral compounds against MAYV.
  • * Synthesis of current knowledge on Mayaro fever therapeutics.

Main Results:

  • * Limited development of specific antiviral treatments for Mayaro fever.
  • * Identification of research gaps in anti-MAYV drug discovery.
  • * Highlighting the urgent need for further investigation into antiviral derivatives.

Conclusions:

  • * There is a critical lack of licensed vaccines or antiviral treatments for Mayaro fever.
  • * The development of effective antiviral drugs against MAYV is urgently required.
  • * Further research into anti-MAYV derivatives is essential to combat potential epidemics.

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
391
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.0K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
610
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K